Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, Advanced Drug Delivery Reviews, (176), p. 113891, 2021

DOI: 10.1016/j.addr.2021.113891

Links

Tools

Export citation

Search in Google Scholar

Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO